Marcus Co. (NYSE:MCS) – Stock analysts at Barrington Research reduced their Q4 2018 earnings per share estimates for shares of Marcus in a research note issued on Tuesday, April 17th. Barrington Research analyst J. Goss now forecasts that the company will post earnings of $0.28
Novanta (NOVT) operates in high-tech markets. The company designs, develops, manufactures, markets, and sells precision photonic and motion control components and subsystems to original equipment manufacturers in the medical equipment and advanced industrial technology markets worldwide.
The company operates in three segments: Photonics, Vision, and Precision Motion. It houses numerous businesses,....More>>>
Baird’sBen Kallo andTyler Frank explain why they’d be buyers of Tesla Motors (TSLA) “at current levels”:
We are upgrading Teslato Outperform and raising our price target to $300. Webelieve investor skepticism has significantly increased since we downgraded TeslaonOct. 6, and although we were concerned about the rate of Model X deliveries,....More>>>
There are lots of articles out there talking about how the smartest move you can make for your retirement is to start saving and investing today. And (of course) if you’re young enough to enjoy the power of compound interest, that is absolutely the best advice out there.
But what about those who are nearing retirement right now? What steps can they take to ensure a healthy and happy....More>>>
Its just a drop in an $8 trillion bucket. But the roughly $50 billion in unconventional assets that the Government Accountability Office (GAO) found in half a million individual retirement accounts (IRAs) at the end of 2015 was enough to sound alarms.
People who invest their retirement accounts in unconventional assetssuch as real estate or virtual currencymay be placing their savings at....More>>>
Gold doesn't trade in a vacuum. Markets are connected. What happens in one often affects others. So if you want to understand what's happening with gold, you need to know what's going on in the markets that affect gold. And while lots of traders focus only on the short term, it's important to have a big-picture view, too. The big picture shows you the long-term....More>>>
Many moons ago, I was assigned to help an internal client analyze a $10 million acquisition; I had drawn the short straw. My advice was to structure the transaction as an asset sale because the risk attached to the stock would be multiples of the purchase price. Of course, the seller wanted a stock sale with a $10 million indemnification. My....More>>>
Both sides of the Brexit negotiation are probing each others’ intentions and capabilities, whilst keeping a close eye upon their own restive and growing populist voters. Their reactions to the growing populist threats come straight from the same page. Prime Minister May has recently rolled out the Conservative Party version of Fabian research, originating in Beatrice and Sidney Webb’s....More>>>
I recently bought shares of seven different companies. One of those companies was AbbVie (NYSE:ABBV). I had different reasons for buying each of the stocks. Some were in sectors in which I didn’t already have much exposure in my portfolio. That wasn’t the case with AbbVie, though. I already owned quite a few healthcare stocks and exchange-traded funds (ETFs).
Luxury shopping is back in vogue in China. Sales growth increased year over year for the first time since growth stalled after Chinese communist leader Xi Jinping began the anti-corruption campaign in 2013. Today, much of the sales growth is coming from within China, with consumers eschewing overseas shopping trips to make their purchases domestically and online.
On Dec. 20, 2017, the shares of Portola Pharmaceuticals (NASDAQ:PTLA), a bioscience specializing in the innovation and commercialization of drugs to treat blood disorders and cancers increased $4.13 to $55.12 (8.09% profits for traders) as of 2:01 pm EST. Previously, in part I and II r
Yesterday, small cap clinical-stage biopharmaceutical stock Cellectis SA (NASDAQ: CLLS) reported that they had received notice fromFDA that a clinical hold was placed on both UCART123 ongoing Phase 1 studies -in acute myeloid leukemia (AML) and in blastic plasmacytoid dendritic cell neoplasm (BPD
Disney (DIS) is a strong company, but it has been negatively affected by changing consumer tastes as far as multichannel video programming distributors are concerned. The decline-at-ESPN story is well-known. Disney therefore needs to replace that revenue/growth with something else; a service to c